We’re running out of antibiotics, and drug companies have little incentive to develop new ones. Can we save the ones we already have?
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?